Current role
Sarah Gheuens
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Agios Pharmaceuticals, Inc. (AGIO)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Agios Pharmaceuticals, Inc. (AGIO) | M.D., Ph.D. Chief Medical Officer, Head of Research & Development | $601,060 | $2,086,680 |
| 2024 | Agios Pharmaceuticals, Inc. (AGIO) | M.D., Ph.D. Chief Medical Officer, Head of Research & Development | $583,495 | $2,544,347 |
| 2023 | Agios Pharmaceuticals, Inc. (AGIO) | M.D., Ph.D. Chief Medical Officer, Head of Research & Development | $566,500 | $2,870,159 |
| 2022 | Agios Pharmaceuticals, Inc. (AGIO) | M.D., Ph.D. Chief Medical Officer, Head of Research & Development | $532,500 | $1,846,903 |
| 2021 | Agios Pharmaceuticals, Inc. (AGIO) | M.D., Ph.D. Chief Medical Officer, Head of Research & Development | $437,583 | $1,169,510 |
| 2020 | Agios Pharmaceuticals, Inc. (AGIO) | M.D., Ph.D. Chief Medical Officer, Head of Research & Development | — | — |
| 2019 | Agios Pharmaceuticals, Inc. (AGIO) | M.D., Ph.D. Chief Medical Officer | — | — |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.